Ovarian Serous Cystadenocarcinoma, also known as serous cystadenoma, is related to cystadenocarcinoma and serous cystadenocarcinoma. An important gene associated with Ovarian Serous Cystadenocarcinoma is TP53 (Tumor Protein P53), and among its related pathways/superpathways are Innate Immune System and Infectious disease. The drugs Cisplatin and Temsirolimus have been mentioned in the context of this disorder. Affiliated tissues include ovary and pancreas, and related phenotypes are Decreased viability and Increased shRNA abundance (Z-score > 2)